VitraveneTM, Innovation in Medicine: A Case Study

First Page		Document Content
Date: 2014-07-15 17:59:18 Medicine HIV/AIDS Viral diseases Ethers Purines Cytomegalovirus retinitis Fomivirsen Antisense therapy Ganciclovir Antivirals Chemistry Biology		VitraveneTM, Innovation in Medicine: A Case Study Add to Reading List Source URL: www.ott.nih.gov Download Document from Source Website File Size: 83,16 KB Share Document on Facebook

	Research Letters AIDS 2005, 19:529–533 Virtual screening of HIV-1 protease inhibitors against human cytomegalovirus protease using docking and molecular dynamics DocID: 1gdqP - View Document
	AIDS Research and Therapy BioMed Central Open Access DocID: 1602b - View Document
	VALGANCICLOVIR ChAMP Monographs DESCRIPTION ChAMP INDICATIONS AND DocID: 11hkH - View Document
	Lions Eye Institute Honours Projects[removed]Research Groups Experimental Immunology 1. Viruses and Autoimmune Disease in the Eye DocID: 10DiK - View Document
	VALCYTE(R) Tablets Pronounced VAL-SITE contains the active ingredient valganciclovir Consumer Medicine Information DocID: Y5Wm - View Document